Episodes

Today, people are living much longer after a cancer diagnosis and treatment than in the past. In this episode, Chuck and Alicia talk with Dr. Anne Blaes, a medical oncologist and leader in cancer survivorship at the University of Minnesota, about what it means to live well with cancer. They look at ...

Today, patients often live a long time after receiving treatment for cancer. For many people, this means they are also living with the after-effects of those treatments, which can impact essential organs like the heart. Dr. Javid Moslehi, a cardiologist, specializes in treating the hearts of cancer ...

This summer, a new targeted treatment for pancreatic cancer was approved by the FDA. The treatment, Rasonque (daraxonrasib), is giving new hope to people with a disease that had been seen as almost untreatable. In this episode, Chuck and Alicia unpack this new development with Dr. Brian Wolpin, dire...

Vaccines have long been used to treat many diseases, but cancer has not historically been one of them. At the Olayan Center for Cancer Vaccines at Memorial Sloan Kettering, Dr. Vinod Balachandran and others are working to change that. In this episode, Chuck talks with Dr. Balachandran about his work...

In the past few decades, we have made huge strides when it comes to reducing mortality from lung cancer. Gone are the days when cigarettes were allowed in restaurants – improvements in prevention, screening, and treatment for lung cancer have completely changed the narrative. In this episode, Alicia...

More than a decade ago, doctors at the University of Pennsylvania treated a patient with her own T cells, which had been engineered to recognize and target the cancer cells in her body. The treatment, which is called CAR T cell immunotherapy, is now widely used for patients with leukemia, lymphoma, ...

New research is helping us to better understand the connections between nutrition and cancer risk. Alicia and Chuck talked with Mathilde Touvier, one of the global researchers studying this issue. She’s a nutritional epidemiologist based in France, and her lab is looking at the effects certain food ...

Huge strides have been made in diagnosing and treating childhood cancers, but most of those benefits are seen in the wealthiest countries in the world. This leaves hundreds of thousands of children in need of adequate cancer care. Dr. André Ilbawi with the World Health Organization tells us about th...

Bladder cancer used to be a disease with very few effective treatment options. That was until two new strategies came on the scene: immunotherapies and antibody drug conjugates. These approaches have changed the way doctors treat bladder cancer, and prolonged the lives of many patients. Dr. Tom Powl...